FDA Approves Cytology Test As First Biomarker-Based Triage Test For Cervical Cancer In Women With HPV

OncLive (3/11, Broderick) reports the FDA approved Roche’s “CINtec® PLUS Cytology test as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas® 4800...